SLITRK1

SLITRK1
Available structures
PDB	Ortholog search: PDBe RCSB
List of PDB id codes
	4RCA, 4RCW
Identifiers
Aliases	SLITRK1 , LRRC12, TTM, SLIT and NTRK like family member 1
External IDs	OMIM: 609678 MGI: 2679446 HomoloGene: 14174 GeneCards: SLITRK1
Gene location (Human)
Chr.	Chromosome 13 (human) [1]
End	83,882,393 bp [1]
Gene ontology
Molecular function	• GO:0001948 protein binding ;
Cellular component	• integral component of membrane ; • membrane ; • synapse ; • extracellular region ; • cell junction ; • cell membrane ; • glutamatergic synapse ; • GABA-ergic synapse ; • integral component of postsynaptic density membrane ;
Biological process	• adult behavior ; • nervous system development ; • multicellular organism growth ; • homeostatic process ; • positive regulation of synapse assembly ; • synapse assembly ; • positive regulation of axonogenesis ; • axonogenesis ; • regulation of synapse organization ; • synaptic membrane adhesion ; • regulation of presynapse assembly ;
	Sources:Amigo / QuickGO
Orthologs
	114798
	76965
	ENSG00000178235
	n/a
	Q96PX8
	Q810C1
	NM_052910 ; NM_001281503
	NM_199065
	NP_001268432 ; NP_443142
	NP_951020
	Wikidata
View/Edit Human	View/Edit Mouse

Last updated September 20, 2020

SLITRK1 ("SLIT and NTRK-like family, member 1") is a human gene that codes for a transmembrane and signalling protein that is part of the SLITRK gene family, which is responsible for synapse regulation and presynaptic differentiation in the brain.^[4]^[5]^[6] Expression of the gene has been linked to early formation of excitatory synapses through binding with receptor tyrosine phosphatase PTP (LAR-RPTP).^[4]^[5] Various studies over the years have linked mutations in the gene to conditions on the OCD spectrum, Tourette syndrome and trichotillomania, however the mutations in the genome itself vary greatly between individuals, with most mutations observed being hard to find in repeat studies.

Members of the SLITRK family, such as SLITRK1, are integral membrane proteins with 2 N-terminal leucine-rich repeat (LRR) domains similar to those of SLIT proteins (see SLIT1; MIM 603742). Most SLITRKs, but not SLITRK1, also have C-terminal regions that share homology with neurotrophin receptors (see NTRK1; MIM 191315). SLITRKs are expressed predominantly in neural tissues and have neurite-modulating activity (Aruga et al., 2003).^[7]

Gene

The gene for SLITRK1 is located on chromosome 13q31.1. The gene is expressed only in the brain of humans. The mRNA can differ from alternative splicing, and contains domains for the extracellular matrix as well as for the LRRs.^[8] Mice contain an ortholog of the gene called Slitrk1.^[7]

Protein structure

SLITRK1 contains 2 horseshoe shaped leucine rich repeat domains (LRRs) in its extracellular domain which are vital to its function.^[4] The LRRs have 6 modules each and are connected by a 70-90 amino acid loops.^[5] LRR1 is a more conserved sequence and is present as a dimer while LRR2 is a monomer and has a more variable sequence.^[5] The conserved sequence of LRR1 contains critical binding pockets and specific charged residues that are important for it to carry out its function of binding to LAR-RPTPs on the N-terminus.^[4]^[5] Both LRR sequences are randomly positioned on the protein and contain variable linker regions.^[5] The protein also contains a short intracellular domain, but lacks a tyrosine phosphorylation motif which is present in other SLITRK genes.^[9]

Function

SLITKR1 is highly expressed in the central nervous system.^[4] It plays a critical part in regulating synapse formation between hippocampal neurons and in differentiation of synapses, helping in neuronal outgrowth.^[4]^[5]^[9]^[10] It is expressed during embryonic stages and postnatally but expression decreases over time and is localized to the postsynaptic membrane.^[4]^[5]

Overexpression of SLITKR1 promotes postsynaptic differentiation for excitatory and inhibitory synapses, but because of the localization only excitatory synapses are affected.^[4] Inhibition of SLITKR1 only reduces differentiation of excitatory synapses because of this.^[4]

Interaction with LAR-RPTP

Since they lack tyrosine phosphorylation motifs, SLITKR1 binds to LAR-RPTP through its LRR1 region in order to differentiate synapses.^[4]^[5] The LRR2 domain's function is not clearly understood yet but it is hypothesised that it is for dimerization to the cell surface.^[4]

LAR-RPTP binds to the LRR1 region through its PTPδ Ig region, with 3 separate binding sites in a 1:1 binding ratio.^[5] Ig1 binds through electrostatic and hydrophobic interactions, Ig2 binds through ionic and hydrogen bonds, and Ig2 binds through hydrogen bonding.^[5] The unique properties on the concave surface are what determine which LAR-RPTP binds to it.^[5] If the proper LAR-RPTP is not bound to the LRR1 then synapse formation cannot occur, but bonding can still occur. Once they are bound properly, the complex is sufficient for synapse differentiation.^[5] Point mutations in the LRR1 region impaired differentiation as well but not binding.^[5]

Clinical significance

Tourette syndrome

The SLITRK1 gene "is not a major risk gene for the majority of individuals" with Tourette syndrome (TS), according to a 2009 review,^[11] although its study can help contribute to our understanding of TS.^[12]^[13] Rare variants in SLITRK1 may lead to TS, and mutations in non-coding regions of SLITRK1 may also play a part, but further research needs to be done before any conclusions can be drawn.^[9]^[14]

In 2005, medical researchers observed a de novo translocation on 13q in a patient with TS which broke the patient's chromosome near the SLITRK1 genome. In screening of additional patients, the authors observed a frameshift mutation in SLITRK1 in a patient with TS and the same rare ncRNA target variant (called var321 and varCDfs; target of miR-24-1) in two patients with TS.^[13] These variants were not found in several thousand controls supporting an association of the variants with TS.^[13]^[15]

A subsequent examination of the region of the SLITRK1 gene found the mutation in none of 82 patients with Tourette syndrome. The authors concluded that tests to detect variant(s) in the gene probably would have little diagnostic utility.^[16] An experiment in the effects of a microdeletion in chromosome 13q31.1 was done in a fetus, the mother had passed the microdeletion to the child and both did not have tourettes or any other OCD symptoms, showing that it may not be a direct cause of tourettes.^[17] Further attempts to replicate the study were done in multiple studies. In a Japanese study, next-gen sequencing was used to screen 92 TS patients and 361 healthy controls, none of TS patients were found to have mutations at either variant or any new mutations in the gene.^[14] In a European study it was found that the 2 original variations were not found in any of the 222 trios that were studied. However, tests were also done on SNPs in the groups and 3 were found to have variations. Two of the three variations were found to be associated with the formation of Tourette syndrome.^[9] In a different study of 381 Caucasians with some form of OCD with 356 non-OCD control patients, 3 genetic changes were found after genetic screening. Of the 3, 2 were identified only once each and the third was found in 4 OCD patients but also in a non-OCD patient.^[10] The non-OCD patient did have compulsive nail biting, but these studies show that a genetic link between SLITRK1 and patients with TS may exist they are more complex in nature than previously understood.^[10]

Trichotillomania

The SLITRK1 gene has also been implicated in a small percentage of cases of trichotillomania, an impulse disorder in which individuals compulsively pull their own hair.^[18]^[8] In one of the previously mentioned studies the mother of the child who had a de novo translocation on 13q had trichotillomania; this would suggest that there could be a genetic link between SLITRK1 and trichotillomania as well.^[10]^[8]

A study was done in which 44 families with individuals who had trichotillomania had their SLITRK1 gene sequenced. Two new non-synonymous mutations were discovered about 9 base pairs apart from each other, in an area separate from the one where the Tourette mutations were found.^[6]^[8] These results were compared to a control and none had the mutation, suggesting that these mutations, while rare, were associated with trichotillomania.^[8]

Related Research Articles

The Wiskott–Aldrich Syndrome protein (WASp) is a 502-amino acid protein expressed in cells of the hematopoietic system that in humans is encoded by the WAS gene. In the inactive state, WASp exists in an autoinhibited conformation with sequences near its C-terminus binding to a region near its N-terminus. Its activation is dependent upon CDC42 and PIP2 acting to disrupt this interaction, causing the WASp protein to 'open'. This exposes a domain near the WASp C-terminus that binds to and activates the Arp2/3 complex. Activated Arp2/3 nucleates new F-actin.

Wiskott–Aldrich syndrome (WAS) is a rare X-linked recessive disease characterized by eczema, thrombocytopenia, immune deficiency, and bloody diarrhea. It is also sometimes called the eczema-thrombocytopenia-immunodeficiency syndrome in keeping with Aldrich's original description in 1954. The WAS-related disorders of X-linked thrombocytopenia (XLT) and X-linked congenital neutropenia (XLN) may present similar but less severe symptoms and are caused by mutations of the same gene.

L1, also known as L1CAM, is a transmembrane protein member of the L1 protein family, encoded by the L1CAM gene. This protein, of 200-220 kDa, is a neuronal cell adhesion molecule with a strong implication in cell migration, adhesion, neurite outgrowth, myelination and neuronal differentiation. It also plays a key role in treatment-resistant cancers due to its function. It was first identified in 1984 by M. Schachner who found the protein in post-mitotic mice neurons.

CTLA4 or CTLA-4, also known as CD152, is a protein receptor that functions as an immune checkpoint and downregulates immune responses. CTLA4 is constitutively expressed in regulatory T cells but only upregulated in conventional T cells after activation – a phenomenon which is particularly notable in cancers. It acts as an "off" switch when bound to CD80 or CD86 on the surface of antigen-presenting cells.

Causes and origins of Tourette syndrome have not been fully elucidated. Tourette syndrome is an inherited neurodevelopmental disorder that begins in childhood or adolescence, characterized by the presence of multiple motor tics and at least one phonic tic, which characteristically wax and wane. Tourette's syndrome occurs along a spectrum of tic disorders, which includes transient tics and chronic tics.

Fibroblast growth factor receptor 2 (FGFR2) also known as CD332 is a protein that in humans is encoded by the FGFR2 gene residing on chromosome 10. FGFR2 is a receptor for fibroblast growth factor.

Neurexins (NRXN) are a family of presynaptic cell adhesion proteins that have roles in connecting neurons at the synapse. They are located mostly on the presynaptic membrane and contain a single transmembrane domain. The extracellular domain interacts with proteins in the synaptic cleft, most notably neuroligin, while the intracellular cytoplasmic portion interacts with proteins associated with exocytosis. Neurexin and neuroligin "shake hands," resulting in the connection between the two neurons and the production of a synapse. Neurexins mediate signaling across the synapse, and influence the properties of neural networks by synapse specificity. Neurexins were discovered as receptors for α-latrotoxin, a vertebrate-specific toxin in black widow spider venom that binds to presynaptic receptors and induces massive neurotransmitter release. In humans, alterations in genes encoding neurexins are implicated in autism and other cognitive diseases, such as Tourette syndrome and schizophrenia.

MT-ND2 is a gene of the mitochondrial genome coding for the NADH dehydrogenase 2 (ND2) protein. The ND2 protein is a subunit of NADH dehydrogenase (ubiquinone), which is located in the mitochondrial inner membrane and is the largest of the five complexes of the electron transport chain. Variants of human MT-ND2 are associated with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), Leigh's syndrome (LS), Leber's hereditary optic neuropathy (LHON) and increases in adult BMI.

Msh homeobox 1, also known as MSX1, is a protein that in humans is encoded by the MSX1 gene. MSX1 transcripts are not only found in thyrotrope-derived TSH cells, but also in the TtT97 thyrotropic tumor, which is a well differentiated hyperplastic tissue that produces both TSHß- and a-subunits and is responsive to thyroid hormone. MSX1 is also expressed in highly differentiated pituitary cells which until recently was thought to be expressed exclusively during embryogenesis. There is a highly conserved structural organization of the members of the MSX family of genes and their abundant expression at sites of inductive cell–cell interactions in the embryo suggest that they have a pivotal role during early development.

43 kDa receptor-associated protein of the synapse (rapsyn) is a protein that in humans is encoded by the RAPSN gene.

MT-ND1 is a gene of the mitochondrial genome coding for the NADH-ubiquinone oxidoreductase chain 1 (ND1) protein. The ND1 protein is a subunit of NADH dehydrogenase, which is located in the mitochondrial inner membrane and is the largest of the five complexes of the electron transport chain. Variants of the human MT-ND1 gene are associated with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS), Leigh's syndrome (LS), Leber's hereditary optic neuropathy (LHON) and increases in adult BMI.

ERG is an oncogene. ERG is a member of the ETS family of transcription factors. The ERG gene encodes for a protein, also called ERG, that functions as a transcriptional regulator. Genes in the ETS family regulate embryonic development, cell proliferation, differentiation, angiogenesis, inflammation, and apoptosis.

Synaptic Ras GTPase-activating protein 1, also known as synaptic Ras-GAP 1 or SYNGAP1, is a protein that in humans is encoded by the SYNGAP1 gene. SYNGAP1 is a ras GTPase-activating protein that is critical for the development of cognition and proper synapse function. Mutations in humans can cause intellectual disability, epilepsy, autism and sensory processing deficits.

Receptor-type tyrosine-protein phosphatase delta is an enzyme that, in humans, is encoded by the PTPRD gene.

Neuroligin-4, X-linked is a protein that in humans is encoded by the NLGN4X gene.

Receptor-type tyrosine-protein phosphatase T is an enzyme that in humans is encoded by the PTPRT gene.

Peroxisomal membrane protein PEX16 is a protein that in humans is encoded by the PEX16 gene.

Neuroligin (NLGN), a type I membrane protein, is a cell adhesion protein on the postsynaptic membrane that mediates the formation and maintenance of synapses between neurons. Neuroligins act as ligands for β-Neurexins, which are cell adhesion proteins located presynaptically. Neuroligin and β-neurexin "shake hands", resulting in the connection between two neurons and the production of a synapse. Neuroligins also affect the properties of neural networks by specifying synaptic functions, and they mediate signalling by recruiting and stabilizing key synaptic components. Neuroligins interact with other postsynaptic proteins to localize neurotransmitter receptors and channels in the postsynaptic density as the cell matures. Additionally, neuroligins are expressed in human peripheral tissues and have been found to play a role in angiogenesis. In humans, alterations in genes encoding neuroligins are implicated in autism and other cognitive disorders.

Chordin-like 1 is a protein that in humans is encoded by the CHRDL1 gene. Chordin-Like 1 (CHRDL1) is a structural glycoprotein that sits on the X chromosome and specifically encodes Venotropin, which is an antagonistic protein to bone morphogenic protein 4.

Glutamate receptor-interacting protein (GRIP) refers to either a family of proteins that bind to the glutamate receptor or specifically to the GRIP1 protein within this family. Proteins in the glutamate receptor-interacting protein (GRIP) family have been shown to interact with GluR2, a common subunit in the AMPA receptor. This subunit also interacts with other proteins such as protein interacting with C-kinase1 (PICK1) and N-ethylmaleimide-sensitive fusion protein (NSF). Studies have begun to elucidate its function; however, much is still to be learned about these proteins.

References

1 2 3 GRCh38: Ensembl release 89: ENSG00000178235 - Ensembl, May 2017
↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
1 2 3 4 5 6 7 8 9 10 11 Beaubien F, Raja R, Kennedy TE, Fournier AE, Cloutier JF (June 2016). "Slitrk1 is localized to excitatory synapses and promotes their development". Scientific Reports. 6: 27343. Bibcode:2016NatSR...627343B. doi:10.1038/srep27343. PMC 4895136 . PMID 27273464.
1 2 3 4 5 6 7 8 9 10 11 12 13 14 Um JW, Kim KH, Park BS, Choi Y, Kim D, Kim CY, Kim SJ, Kim M, Ko JS, Lee SG, Choii G, Nam J, Heo WD, Kim E, Lee JO, Ko J, Kim HM (November 2014). "Structural basis for LAR-RPTP/Slitrk complex-mediated synaptic adhesion". Nature Communications. 5: 5423. Bibcode:2014NatCo...5.5423U. doi: 10.1038/ncomms6423 . PMID 25394468.
1 2 Chattopadhyay K, Chatterjee K (August 2012). "The genetic factors influencing the development of trichotillomania". Journal of Genetics. 91 (2): 259–62. doi:10.1007/s12041-011-0094-6. PMID 22942103.
1 2 "Entrez Gene: SLITRK1 SLIT and NTRK-like family, member 1".
1 2 3 4 5 Zuchner S, Cuccaro ML, Tran-Viet KN, Cope H, Krishnan RR, Pericak-Vance MA, Wright HH, Ashley-Koch A (October 2006). "SLITRK1 mutations in trichotillomania". Molecular Psychiatry. 11 (10): 887–9. doi: 10.1038/sj.mp.4001865 . PMID 17003809.
1 2 3 4 Karagiannidis I, Rizzo R, Tarnok Z, Wolanczyk T, Hebebrand J, Nöthen MM, Lehmkuhl G, Farkas L, Nagy P, Barta C, Szymanska U, Panteloglou G, Miranda DM, Feng Y, Sandor P, Barr C, Paschou P (July 2012). "Replication of association between a SLITRK1 haplotype and Tourette Syndrome in a large sample of families". Molecular Psychiatry. 17 (7): 665–8. doi: 10.1038/mp.2011.151 . PMID 22083730.
1 2 3 4 Ozomaro U, Cai G, Kajiwara Y, Yoon S, Makarov V, Delorme R, Betancur C, Ruhrmann S, Falkai P, Grabe HJ, Maier W, Wagner M, Lennertz L, Moessner R, Murphy DL, Buxbaum JD, Züchner S, Grice DE (2013). "Characterization of SLITRK1 variation in obsessive-compulsive disorder". PLOS ONE. 8 (8): e70376. Bibcode:2013PLoSO...870376O. doi:10.1371/journal.pone.0070376. PMC 3749144 . PMID 23990902.
↑ O'Rourke JA, Scharf JM, Yu D, Pauls DL (2009). "The genetics of Tourette syndrome: a review". J Psychosom Res. 67 (6): 533–45. doi:10.1016/j.jpsychores.2009.06.006. PMC 2778609 . PMID 19913658.
↑ Grados MA, Walkup JT (June 2006). "A new gene for Tourette's syndrome: a window into causal mechanisms?". Trends in Genetics. 22 (6): 291–3. doi:10.1016/j.tig.2006.04.003. PMID 16678301.
1 2 3 Abelson JF, Kwan KY, O'Roak BJ, Baek DY, Stillman AA, Morgan TM, Mathews CA, Pauls DL, Rasin MR, Gunel M, Davis NR, Ercan-Sencicek AG, Guez DH, Spertus JA, Leckman JF, Dure LS, Kurlan R, Singer HS, Gilbert DL, Farhi A, Louvi A, Lifton RP, Sestan N, State MW (October 2005). "Sequence variants in SLITRK1 are associated with Tourette's syndrome". Science. 310 (5746): 317–20. Bibcode:2005Sci...310..317A. doi:10.1126/science.1116502. PMID 16224024.
1 2 Inai A, Tochigi M, Kuwabara H, Nishimura F, Kato K, Eriguchi Y, Shimada T, Furukawa M, Kawamura Y, Sasaki T, Kakiuchi C, Kasai K, Kano Y (December 2015). "Analysis of SLITRK1 in Japanese patients with Tourette syndrome using a next-generation sequencer". Psychiatric Genetics. 25 (6): 256–8. doi:10.1097/YPG.0000000000000104. PMID 26317387.
↑ Larsen, K; Momeni, J; Farajzadeh, L; Bendixen, C (2014). "Porcine SLITRK1: Molecular cloning and characterization". FEBS Open Bio. 4: 872–8. doi:10.1016/j.fob.2014.10.001. PMC 4215120 . PMID 25379384.
↑ Deng H, Le WD, Xie WJ, Jankovic J (December 2006). "Examination of the SLITRK1 gene in Caucasian patients with Tourette syndrome". Acta Neurologica Scandinavica. 114 (6): 400–2. doi:10.1111/j.1600-0404.2006.00706.x. PMID 17083340.
↑ Jia Y, Zhao H, Shi D, Peng W, Xie L, Wang W, Jiang F, Zhang H, Wang X (2014). "Genetic effects of a 13q31.1 microdeletion detected by noninvasive prenatal testing (NIPT)". International Journal of Clinical and Experimental Pathology. 7 (10): 7003–11. PMC 4230093 . PMID 25400788.
↑ Chamberlain SR, Menzies L, Sahakian BJ, Fineberg NA (April 2007). "Lifting the veil on trichotillomania". The American Journal of Psychiatry. 164 (4): 568–74. doi:10.1176/appi.ajp.164.4.568. PMID 17403968.